91官网入口丨少妇搡bbbb搡bbb搡澳门丨九九久久精品视频丨日本无遮挡大尺度床戏网站丨亚洲国产综合人成综合网站丨五十路av在线丨午夜视频在线观看视频丨国产偷人爽久久久久久老妇app丨色综合久久久久久久久五月丨里番acg☆里番本子全彩丨天天做天天欢摸夜夜摸狠狠摸丨国产成人精品午夜视频丨欧美在线视频a丨欧美中文字幕一区二区丨17c在线视频在线观看丨精品久久久久久无码免费丨久久av免费观看丨国产精品1000丨少妇被猛烈进入到喷白浆丨毛片xxx

Output value of biomedical industry in SIP reaches RMB 90 billion in 2019

SIP started deployment for biomedical industry in 2007. Since then, the industry has maintained an annual growth of more than 20% in total output value, which reached RMB 90 billion last year. This has enabled SIP to rank among the country’s best clusters of biomedicine businesses. Statistics show that SIP recorded a long list of new drugs that received approvals last year for clinical trials, which account for 10% of the national total, and of them, new biological drugs developed in SIP accounted for 20% of the national total.[MORE]